Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2Phase 4 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 36Genitourinary 6Gynecologic 5Sarcoma 3Head & Neck 3Thoracic 1Other hematologic neoplasm 1CNS 1

Conditions

Head and Neck Neoplasms 3Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma 2Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Bleomycin × Head & Neck × Clear all
NCT00198315 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 3 Terminated
130 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

NCT00198328 2022-03-04

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 3 Terminated
84 enrolled
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

NCT00002476 2013-08-02

Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡